Medipax Injection (Fluphenazine) | Used for Schizophrenia and Psychotic Disorder Treatment
Medipax Injection (Fluphenazine) is an antipsychotic medicine used for the treatment and long-term management of schizophrenia and other psychotic disorders. It works by balancing certain brain chemicals to help reduce symptoms such as hallucinations, delusions, disorganized thinking, and behavioral disturbances.
Product Overview
Medipax Injection is a long-acting, second-generation conventional (typical) antipsychotic medication formulated for deep intramuscular administration. Containing the active compound Fluphenazine Decanoate, this injection is explicitly engineered for the maintenance therapy of chronic schizophrenia. The active drug is esterified and dissolved in a sesame oil base, allowing for a slow, continuous release from the injection site into the bloodstream. This sustained-release profile provides stable therapeutic coverage for several weeks, making it a critical intervention for patients who struggle with daily oral medication compliance or suffer from recurrent psychotic relapses.
Product Composition
- Active Pharmaceutical Ingredient: Fluphenazine Decanoate (standardly concentrated at 25mg per 1mL of solution)
- Dosage Form: Sterile, clear, pale yellow, viscous oil solution optimized for depot intramuscular injection
- Core Excipients: Formulated inside a purified sesame oil vehicle to establish the repository effect, stabilized with benzyl alcohol added as a preservative
Product Specification
| Product Parameter | Details |
| Brand Name | Medipax Injection |
| Active Ingredient | Fluphenazine Decanoate |
| Therapeutic Class | Central Nervous System Agents / Phenothiazine Antipsychotics |
| Available Strength | 25mg/mL |
| Primary Indications | Long-term maintenance management of chronic schizophrenia and related psychotic disorders |
Mechanism of Action
- Postsynaptic Dopamine D2 Receptor Blockade: Fluphenazine acts as a potent antagonist at postsynaptic dopamine D2 receptors within the mesolimbic and mesocortical pathways of the brain. By blocking hyperactive dopaminergic transmission, it suppresses positive psychotic symptoms including disorganized speech, hallucinations, and paranoia.
- Depot Release Kinetics: The decanoate ester group creates a highly hydrophobic molecule that remains localized inside the muscular tissue. Tissue esterases slowly cleave the decanoate chain over days and weeks, releasing free fluphenazine gradually into systemic circulation.
- Alpha-1 Adrenergic and Histaminergic Antagonism: The drug exhibits moderate antagonistic affinity for peripheral alpha-1 adrenergic receptors and central H1 histaminergic receptors, contributing to potential orthostatic blood pressure drops and baseline sedation.
- Basal Ganglia Dopamine Inhibition: Secondary blockade of dopamine pathways within the nigrostriatal tract is responsible for the drug's high propensity to alter motor function and induce extrapyramidal movement symptoms.
Key Benefits
- Ensures consistent, predictable delivery of antipsychotic medication for up to four weeks, completely eliminating the reliance on daily patient compliance with oral tablets.
- Significantly reduces psychiatric relapse rates and minimizes emergency re-hospitalization cycles by preventing sudden drops in circulating blood plasma levels.
- The slow release from the intramuscular depot avoids the high, sharp concentration peaks associated with oral dosing, leading to more stable, baseline symptom control.
- Provides an established, clinically proven therapeutic pathway for stabilizing long-term cognitive and behavioral performance in patients with severe, chronic psychotic conditions.
Precautions
Important Precautions for Medipax Injection (Fluphenazine)
Medipax Injection is an antipsychotic medicine used for schizophrenia and psychotic disorders. It should be used carefully due to its effects on the nervous system, movement control, and mental status.
| Precaution Area | Details |
|---|---|
| Movement Disorders | May cause tremors, stiffness, or involuntary movements. |
| Sedation | Can cause drowsiness and reduced alertness. |
| Heart Conditions | Use cautiously in heart rhythm disorders. |
| Elderly Patients | Higher risk of serious side effects, especially dementia-related psychosis. |
| Seizure Disorders | Use with caution in epilepsy patients. |
| Liver Function | Careful monitoring may be needed. |
| Heat Sensitivity | May reduce body’s ability to regulate temperature. |
Important Safety Advice
- Take or receive injection exactly as prescribed
- Avoid alcohol during treatment
- Do not stop treatment suddenly without medical advice
- Monitor for unusual muscle movements or stiffness
- Avoid driving if drowsiness occurs
When to Avoid Medipax Injection
- Known allergy to Fluphenazine or phenothiazines
- Severe central nervous system depression
- Parkinson’s disease (use cautiously)
- Severe liver disease
Monitoring Requirements
- Mental health and symptom improvement monitoring
- Blood pressure and heart rhythm checks
- Observation for movement-related side effects
- Liver function tests if required
General Note
- Regular psychiatric follow-up is essential
- Long-term use may require dose adjustments
- Report muscle stiffness, fever, or unusual movements immediately
Usage
This long-acting depot injection must be administered exclusively by a trained healthcare professional in a clinical setting. Because the medication releases slowly from the muscle tissue over several weeks, dosing adjustments are made gradually, and patients must be monitored closely for movement disorders or changes in blood pressure.
| Parameter | Clinical Guidelines |
| Administration Route | Administered strictly via deep intramuscular injection, preferably into the upper outer quadrant of the gluteal muscle. It must never be given intravenously. |
| Motor Side Effect Monitoring | Patients should be routinely evaluated for extrapyramidal symptoms like muscle rigidity or tremors. Anticholinergic medications may be co-prescribed to manage these reactions. |
| Therapeutic Transition | When switching from oral fluphenazine to the depot injection, the oral dosage is tapered off gradually as the injection achieves stable therapeutic blood levels. |
Uses
Long-Term Maintenance of Chronic Schizophrenia: Indicated to provide a continuous, stable baseline level of antipsychotic medication to control core symptoms like disorganized thinking, hallucinations, and delusions over extended periods.
Prevention of Psychotic Relapse: Utilized to reduce the risk of symptom recurrence in patients with a clinical history of frequent relapses or psychiatric hospitalizations.
Stabilization for Non-Compliant Patients: Prescribed as a reliable alternative for individuals who face difficulties maintaining a daily oral medication schedule, ensuring consistent therapeutic coverage.
Sustained Behavioral Stabilization: Employed to help maintain long-term cognitive baseline performance, social integration, and behavioral stability in chronic psychotic disorders.
Side Effects
Possible Side Effects of Medipax Injection (Fluphenazine)
Medipax Injection is an antipsychotic medicine used for schizophrenia and psychotic disorders. Side effects may occur due to its effects on the brain, movement control, and nervous system.
| Side Effect Type | Details |
|---|---|
| Common Effects | Drowsiness, dizziness, fatigue. |
| Movement Disorders | Tremors, muscle stiffness, restlessness. |
| Nervous System | Sedation, headache. |
| Digestive System | Dry mouth, constipation. |
| Cardiovascular | Low blood pressure, palpitations. |
| Serious Effects | Tardive dyskinesia, neuroleptic malignant syndrome (rare). |
Common Side Effects
- Drowsiness
- Dizziness
- Muscle stiffness or tremors
- Dry mouth
Less Common But Important Effects
- Restlessness (akathisia)
- Constipation or blurred vision
- Low blood pressure or fainting
- Weight changes
When to Be Careful
- Severe muscle stiffness with fever
- Uncontrolled body or facial movements
- Fainting or irregular heartbeat
- Severe confusion or extreme drowsiness
General Note
- Side effects may be more noticeable during early treatment
- Long-term use may increase movement-related risks
- Regular psychiatric monitoring is important
- Report severe or persistent symptoms promptly
FAQs
Q: What is Medipax Injection used for?
A: This long-acting injection is a typical antipsychotic used for the long-term maintenance treatment of chronic schizophrenia. It is especially beneficial for patients who require stable medication levels or struggle with taking daily oral tablets.
Q: How often is this injection administered?
A: Because the medication is suspended in an oil base, it releases very slowly into the body. A healthcare professional typically administers the injection once every 2 to 4 weeks, depending on your individual response and clinical requirements.
Q: Where and how should Medipax Injection be given?
A: It must be administered strictly by a healthcare professional as a deep intramuscular injection, usually into the gluteal (buttock) muscle. It must never be given intravenously.
Q: What are extrapyramidal symptoms (EPS)?
A: EPS are involuntary movement side effects common with typical antipsychotics. They include muscle stiffness, tremors, restlessness or an inability to sit still (akathisia), drooling, and unusual eye or tongue movements. Your doctor may prescribe secondary medications to manage these symptoms if they occur.
Q: Can this injection cause dizziness when standing up?
A: Yes, it can cause orthostatic hypotension, which is a sudden drop in blood pressure when moving from a sitting or lying position to standing. Patients should change positions slowly to prevent dizziness, lightheadedness, or fainting.
Q: What is Tardive Dyskinesia?
A: This is a serious, potentially irreversible movement disorder that can develop with long-term use of antipsychotic medications. It causes repetitive, uncontrollable facial movements such as lip-smacking, tongue thrusting, blinking, or grimacing. Report any unusual movements to your doctor immediately.
Q: Is it safe to consume alcohol while on this medication?
A: No, alcohol should be strictly avoided. Medipax deepens the depressive effects on the central nervous system, and combining it with alcohol can cause extreme drowsiness, severe breathing difficulties, and dangerous drops in blood pressure.
Q: Can you stop taking the injection if your symptoms disappear?
A: No, you should not stop the treatment program. Even if you feel entirely better, stopping the maintenance therapy can cause your schizophrenia symptoms to gradually return or severely worsen over the following weeks. Any discontinuation must be carefully planned and supervised by your psychiatrist.
Interactions
Drug Interactions of Medipax Injection (Fluphenazine)
Medipax Injection (Fluphenazine) may interact with medicines that affect the brain, heart rhythm, or nervous system. These interactions can increase sedation, movement-related side effects, or cardiac risks.
| Medicine or Product Type | Interaction Details |
|---|---|
| Sedatives / Sleeping Pills | May increase drowsiness and CNS depression. |
| Alcohol | Enhances sedation and impaired alertness. |
| Antidepressants | May increase side effects or affect heart rhythm. |
| Other Antipsychotics | Increased risk of movement disorders and sedation. |
| Antihypertensives | May increase risk of low blood pressure. |
| Anticholinergic Medicines | Can worsen dry mouth, constipation, or blurred vision. |
| Seizure Medicines | May alter seizure threshold or medicine response. |
Important Interaction Advice
- Avoid alcohol during treatment
- Inform doctor about all psychiatric medications in use
- Use caution with medicines causing drowsiness
- Monitor for dizziness, stiffness, or unusual movements
General Guidance
- Regular monitoring may be required in combination therapy
- Dose adjustments may be needed with interacting medicines
- Report fainting, palpitations, or severe muscle stiffness immediately
- Always share complete medication history before treatment
Additional Note
- Medipax Injection has significant central nervous system interaction potential, making psychiatric supervision important during treatment
| Manufacturer | : | Alteus Biogenics Pvt Ltd |
| Trade Name | : | Prolixin |
| Generic Search | : | Fluphenazine |
| Strength | : | 25mg |
Latest Products
